MANCUSO, ANTONIA
 Distribuzione geografica
Continente #
NA - Nord America 340
EU - Europa 208
AS - Asia 114
OC - Oceania 2
SA - Sud America 1
Totale 665
Nazione #
US - Stati Uniti d'America 338
IT - Italia 135
SG - Singapore 64
DE - Germania 20
GB - Regno Unito 19
CN - Cina 18
IN - India 12
FI - Finlandia 8
SE - Svezia 8
NL - Olanda 7
TR - Turchia 5
PH - Filippine 4
DK - Danimarca 3
FR - Francia 3
HK - Hong Kong 3
IR - Iran 3
KR - Corea 3
AU - Australia 2
CA - Canada 2
RU - Federazione Russa 2
TW - Taiwan 2
CL - Cile 1
HU - Ungheria 1
PL - Polonia 1
RO - Romania 1
Totale 665
Città #
Ashburn 53
Singapore 49
Santa Clara 37
Chandler 24
Milan 23
Chicago 16
London 15
Boardman 14
Princeton 14
Lawrence 12
Washington 12
Wilmington 11
Los Angeles 10
Helsinki 8
Naples 8
Lamezia Terme 6
Rome 6
Seattle 6
Bursa 5
Catania 5
Melito di Porto Salvo 5
Assago 4
Bisignano 4
Enfield 4
Hamelin 4
Mumbai 4
Munich 4
Parma 4
Redmond 4
Catanzaro 3
Copenhagen 3
Des Moines 3
Phoenix 3
Seoul 3
Thrissur 3
Amsterdam 2
Bologna 2
Florence 2
Guangzhou 2
Hanover 2
Pune 2
San Sostene 2
Santo Stefano di Rogliano 2
Spoltore 2
Taipei 2
Tehran 2
Aversa 1
Berlin 1
Cologne 1
Cosenza 1
Formia 1
Guiyang 1
Gunzenhausen 1
Hamm 1
Kemerovo 1
Kozhikode 1
Langfang 1
Leawood 1
Logan 1
Mashhad 1
Montreal 1
New York 1
Ottawa 1
Paravati 1
Paris 1
Ravenna 1
Roccabernarda 1
San Nicola Manfredi 1
Settingiano 1
Sorrento 1
Stockholm 1
Szeged 1
Taiyuan 1
Vallefiorita 1
Wernigerode 1
Yichun 1
Totale 441
Nome #
Injectable Drug Delivery Systems for Osteoarthritis and Rheumatoid Arthritis 40
Targeting of the pilosebaceous follicle by liquid crystal nanocarriers: In vitro and in vivo effects of the entrapped minoxidil 36
Cardiac Stem Cell-Loaded Delivery Systems: A New Challenge for Myocardial Tissue Regeneration. 35
Nanonutraceuticals: The new frontier of supplementary food 32
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 31
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 30
Ammonium Glycyrrhizinate and Bergamot Essential Oil Co-Loaded Ultradeformable Nanocarriers: An Effective Natural Nanomedicine for In Vivo Anti-Inflammatory Topical Therapies 29
A comparison between silicone-free and silicone-based emulsions: Technological features and in vivo evaluation 28
Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation 24
Rutin-loaded nanovesicles for improved stability and enhanced topical efficacy of natural compound 22
Oleic acid-based vesicular nanocarriers for topical delivery of the natural drug thymoquinone: Improvement of anti-inflammatory activity 22
Improvement of Ferulic Acid Antioxidant Activity by Multiple Emulsions: In Vitro and In Vivo Evaluation 22
Positively Charged Lipid as Potential Tool to Influence the Fate of Ethosomes 22
Nanonized carbamazepine for nose-to-brain delivery: pharmaceutical formulation development 21
In vitro and in vivo trans-epidermal water loss evaluation following topical drug delivery systems application for pharmaceutical analysis 21
The Rheolaser Master™ and Kinexus rotational rheometer® to evaluate the influence of topical drug delivery systems on rheological features of topical poloxamer gel 21
Influence of Materials Properties on Bio-Physical Features and Effectiveness of 3D-Scaffolds for Periodontal Regeneration 20
Oleuropein-Laded Ufasomes Improve the Nutraceutical Efficacy 19
Topical Unsaturated Fatty Acid Vesicles Improve Antioxidant Activity of Ammonium Glycyrrhizinate 19
The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives 18
Sulforaphane-loaded ultradeformable vesicles as a potential natural nanomedicine for the treatment of skin cancer diseases 18
EtoGel for Intra-Articular Drug Delivery: A New Challenge for Joint Diseases Treatment 16
Olive Leaves and Citrus Peels: From Waste to Potential Resource for Cosmetic Products 16
Icariin-Loaded Transfersomes® as a Potential Nanomedicine for Skin Disorders 15
Lyotropic Liquid Crystals: A Biocompatible and Safe Material for Local Cardiac Application 14
Gelled Liquid Crystal Nanocarriers for Improved Antioxidant Activity of Resveratrol 14
Chitosan/Cyclodextrin Nanospheres for Potential Nose-to-Brain Targeting of Idebenone 13
In Situ Swelling Formulation of Glycerol-Monooleate-Derived Lyotropic Liquid Crystals Proposed for Local Vaginal Application 13
Improved anti-breast cancer activity by doxorubicin-loaded super stealth liposomes 13
Skin Tolerability of Oleic Acid Based Nanovesicles Designed for the Improvement of Icariin and Naproxen Percutaneous Permeation 12
The challenge of nanovesicles for selective topical delivery for acne treatment: Enhancing absorption whilst avoiding toxicity 12
Author Correction: Perspective use of bio-adhesive liquid crystals as ophthalmic drug delivery systems (Scientific Reports, (2023), 13, 1, (16188), 10.1038/s41598-023-42185-z) 11
Vegetable-milk-based yogurt-like structure: Rheological properties influenced by gluten-free carob seed flour 11
Antimicrobial Compounds from Food Waste in Cosmetics 9
OX26-cojugated gangliosilated liposomes to improve the post-ischemic therapeutic effect of CDP-choline 7
Perspective use of bio-adhesive liquid crystals as ophthalmic drug delivery systems 5
Reflectance spectroscopy: a non-invasive strategy to explore skin reactions to topical products 5
Totale 716
Categoria #
all - tutte 8.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/202127 0 0 0 4 4 4 4 0 9 1 1 0
2021/202237 5 0 0 7 2 0 0 9 8 1 4 1
2022/2023163 26 3 9 1 12 9 1 13 15 20 47 7
2023/2024253 39 18 24 19 19 58 11 12 4 3 7 39
2024/2025233 60 11 10 19 46 64 23 0 0 0 0 0
Totale 716